Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Pharma
Teva's 1st R&D day lets CEO bask in innovative drug refresh
TD Cowen analysts left Teva's first R&D day this week feeling “increasingly confident” in the firm’s direction.
Fraiser Kansteiner
,
Donavyn Coffey
Nov 13, 2026 11:16am
Fierce Biotech
BMS reunites R&D divisions under Massacesi as Plenge departs
Nov 12, 2026 8:16am
Amid Dupixent boom, Sanofi looks hard at its R&D future
Oct 30, 2026 11:50am
GSK pledges $800M to upgrade its R&D, manufacturing in PA
Oct 9, 2026 4:13pm
Mucinex maker invests $600 million in US operations overhaul
Sep 16, 2026 10:30am
How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Aug 21, 2026 11:30am